RTSN
NASDAQRetension Pharmaceuticals Inc.
Retension Pharmaceuticals Inc. (RTSN) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for RTSN, including 2 insider trades and 1 press release or news item. The most recent was published Nov 5, 2026.
RTSN rankings
News · 26 weeks3+100%
2026-05-172026-11-08
Mix390d
- Insider2(67%)
- Other1(33%)
Activity · 52 weeks32 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
3 items- PRRetension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation ConferenceFALLS CHURCH, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) ("Retension" or the "Company"), a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases, announced today that management will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference, taking place November 9–11, 2026, in Boston, Massachusetts. Event: Guggenheim 3rd Annual Healthcare Innovation ConferenceFormat: Fireside chatDate: Tuesday, November 10, 2026Time: 7:30 a.m. ET A live webcast of this fireside chat can also be accessed on the "News & Events" page in the Inve
- INSIDERVP, Chief Accounting Officer Wong Robert was granted 25,000 stock options (SEC Form 4)4 - Retension Pharmaceuticals, Inc. (0002002988) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wong Robert3 - Retension Pharmaceuticals, Inc. (0002002988) (Issuer)
RTSN FAQ
7 questionsWhat does Retension Pharmaceuticals Inc. do?
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. The Company's lead clinical candidate, RTN-001, is in development for patients with uncontrolled and resistant hypertension.What is the latest news on RTSN?
In the last 30 days Quantisnow tracked 3 wire items for RTSN: 2 insider trades and 1 press release or news item. The most recent was published on November 5, 2026.Where does RTSN stock trade?
Retension Pharmaceuticals Inc. (RTSN) is listed on NASDAQ.What sector and industry is RTSN in?
Retension Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Retension Pharmaceuticals Inc. go public?
Retension Pharmaceuticals Inc. (RTSN) completed its IPO in 2026.What companies are similar to RTSN?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare RTSN side-by-side with any of them on Quantisnow.How can I track RTSN on Quantisnow?
Quantisnow aggregates Retension Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RTSN to receive live email and push alerts on every new disclosure.